References
- Akram, A., et al., 2016. Preventive effects of betulinic acid on streptozotocinnicotinamide induced diabetic nephropathy in male mouse. Journal of nephropathology, 5 (4), 128–133.
- Bailey, C.J., 1999. Insulin resistance and antidiabetic drugs. Biochemical pharmacology, 58 (10), 1511–1520.
- Carvalho, E., et al., 2001. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB journal, 15 (6), 1101–1103.
- Castellano, J.M., et al., 2013. Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes, 62 (6), 1791–1799.
- Cawthorn, W.P., and Sethi, J.K., 2008. TNF-alpha and adipocyte biology. FEBS letters, 582 (1), 117–131.
- Choi, J.Y., et al., 2009. Isolation of betulinic acid, its methyl ester and guaiane sesquiterpenoids with protein tyrosine phosphatase 1B inhibitory activity from the roots of Saussurea lappa. Molecules, 14 (1), 266–272.
- Donath, M.Y., 2013. Targeting inflammation in the treatment of type 2 diabetes. Diabetes, obesity and metabolism, 15 (s3), 193–196.
- Feng, J., et al., 2020. The role of JNk signalling pathway in obesity-driven insulin resistance. Diabetes, metabolic syndrome and obesity, 13, 1399–1406.
- Fernandez-Real, J.M., and Ricart, W., 2003. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine reviews, 24 (3), 278–301.
- Genet, C., et al., 2010. Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes. Journal of medicinal chemistry, 53 (1), 178–190.
- Gloria, B., et al., 2017. Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis. Scientific reports, 7, 5777.
- Golshan, A.B., et al., 2018. Anti-diabetic effect of betulinic acid on streptozotocin-nicotinamide induced diabetic male mouse model. Braz. Journal of pharmaceutical sciences, 54 (02), 217171.
- Gonzalez-Rodriguez, A., et al., 2010. Inhibition of PTP1B restores IRS1-mediated hepatic insulin signalling in IRS2-deficient mice. Diabetes, 59 (3), 588–599.
- Gorjão, R., et al., 2012. Molecular mechanisms involved in inflammation and insulin resistance in chronic diseases and possible interventions. Journal of biomedicine and biotechnology., 2012, 1–2.
- Han, J., et al., 2015. Pentacyclic Triterpenoids from Astilbe rivularis that enhance glucose uptake via the activation of Akt and Erk1/2 in C2C12 Myotubes. Journal of natural products, 78 (5), 1005–1014.
- Han, M.S., et al., 2013. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science, 339 (6116), 218–222.
- Hotamisligil, G.S., et al., 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science, 271 (5249), 665–8668.
- Hu, X., et al., 2014. Triterpenoid saponins from Stauntonia chinensis ameliorate insulin resistance via the AMP-activated protein kinase and IR/IRS-1/PI3K/Akt pathways in insulin-resistant HepG2 cells. International journal of molecular sciences, 15 (6), 10446–10458.
- Huafang, D., et al., 2018. New insights into the inhibition mechanism of betulinic acid on α-Glucosidase. Journal of agricultural and food chemistry, 66 (27), 7065–7075.
- Jia, X., et al., 2021. Alismatis Rhizoma triterpenes alleviate high-fat diet-induced insulin resistance in skeletal muscle of mice. Evidence-based complementary and alternative medicine, 2021 (5), 8857687–15.
- Jiang, C., Liang, L., and Guo, Y., 2012. Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades. Acta Pharmacologica Sinica, 33 (10), 1217–1245.
- Jung, S.H., et al., 2007. Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator. The biochemical journal, 403 (2), 243–250.
- Khan, M.F., et al., 2014. Design and synthesis of lupeol analogues and their glucose uptake stimulatory effect in L6 skeletal muscle cells. Bioorganic and medicinal chemistry letters, 24 (12), 2674–2679.
- Kim, K.D., et al., 2019. Metabolism and Cardiovascular Disease. Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK. Nutrition, metabolism, and cardiovascular diseases, 29 (4), 409–420.
- Kim, S.J., et al., 2014. Beneficial effect of betulinic acid on hyperglycemia via suppression of hepatic glucose production. Journal of agricultural and food chemistry, 62 (2), 434–442.
- Lee, J., et al., 2021. Plant extracts for type 2 diabetes: from traditional medicine to modern drug discovery. Antioxidants, 10 (1), 81.
- Lee, Y.H., et al., 2003. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signalling cascade. The journal of biological chemistry, 278 (5), 2896–2902.
- Li, J., et al., 2000. Reduced glucose uptake precedes insulin signalling defects in adipocytes from heterozygous GLUT4 knockout mice. FASEB journal, 14 (9), 1117–1125.
- Melo, C.L., et al., 2009. Betulinic acid, a natural pentacyclic triterpenoid, prevents abdominal fat accumulation in mice fed a high-fat diet. Journal of agricultural and food chemistry, 57 (19), 8776–8781.
- Moghaddam, M.G., et al., 2012. Biological activity of betulinic acid: a review. Pharmacology & pharmacy, 3 (2), 119–123.
- Na, M., et al., 2009. Inhibition of protein tyrosine phosphatase 1B by lupeol and lupenone isolated from Sorbus commixta. Journal of enzyme inhibition and medicinal chemistry, 24 (4), 1056–1059.
- Nieto-Vazquez, I., et al., 2007. Protein–tyrosine phosphatase 1B–deficient myocytes show increased insulin sensitivity and protection against tumour necrosis factor-α–induced insulin resistance. Diabetes, 56 (2), 404–413.
- Nieto-Vazquez, I., et al., 2008. Insulin resistance associated to obesity: the link TNF-alpha. Archives of physiology and biochemistry, 114 (3), 183–194.
- Patil, K.R., et al., 2015. Pentacyclic Triterpenoids inhibit IKKβ mediated activation of NF-κB pathway: in silico and in vitro evidences. PLoS one, 10 (5), e0125709.
- Pirart, J., 1977. Diabetes mellitus and its degenerative compilations: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes & metabolism journal, 3, 168–172.
- Rabi, T., Shukla, S., and Gupta, S., 2008. Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells. Molecular carcinogenesis, 47 (12), 964–973.
- Ríos, J.L., and Manez, S., 2018. New pharmacological opportunities for betulinic acid. Planta Medica, 84 (1), 8–19.
- Saltiel, A.R., and Kahn, C.R., 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414 (6865), 799–806.
- Shishodia, S., et al., 2003. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaB alpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D. Cancer research, 63 (15), 4375–4383.
- Solinas, G., and Becattini, B., 2017. JNK at the crossroad of obesity, insulin resistance, and cell stress response. Molecular metabolism, 6 (2), 174–184.
- Virkamaki, A., Ueki, K., and Kahn, C.R., 1999. Protein–protein interaction in insulin signalling and the molecular mechanisms of insulin resistance. The journal of clinical investigation, 103 (7), 931–943.
- Wilcox, G., 2005. Insulin and insulin resistance. The clinical biochemist. reviews, 26 (2), 19–39.
- Yang, R., and Trevillyan, J.M., 2008. c-Jun N-terminal kinase pathways in diabetes. The international journal of biochemistry & cell biology, 40 (12), 2702–2706.
- Yang, R., et al., 2007. Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice. The journal of biological chemistry, 282 (31), 22765–22774.
- Yoon, J.J., et al., 2010. Protective role of betulinic acid on TNF-alpha-induced cell adhesion molecules in vascular endothelial cells. Biochemical and biophysical research communications, 391 (1), 96–101.
- Zhang, Y.N., et al., 2008. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities. Bioorganic & medicinal chemistry, 16 (18), 8697–8705.
- Zimmet, P., Alberti, K., and Shaw, J., 2001. Global and societal implications of the diabetes epidemic. Nature, 414 (6865), 782–787.